Literature DB >> 19738942

Rat subcutaneous tissue response to modified Portland cement, a new mineral trioxide aggregate.

Ricardo Martínez Lalis1, María Laura Esaín, Gabriel A Kokubu, Julia Willis, Carolina Chaves, Daniel R Grana.   

Abstract

The purpose of this study was compare the biocompatibility of modified Portland cement (CPM) and mineral trioxide aggregate (MTA) in a subcutaneous rat model. Twenty-four male Wistar rats were used. Three silicon tubes were placed on the dorsal subcutaneous tissue of each animal: one tube contained MTA, one tube contained CPM and the other was an empty tube. The rats were sacrificed in 3 groups of 8 animals at 7, 14 and 30 postoperative days, respectively. Tissue samples were fixed in 10% buffered formalin, embedded in paraffin, and serial sections were cut and stained with hematoxylin and eosin, Masson Trichrome and Luna's stain. At day 7, the empty tubes displayed a mild inflammatory infiltrate. In the CPM group, an inflammatory infiltrate was observed with some eosinophils and immature connective tissue. The MTA group showed a similar infiltrate without eosinophils and presence of abundant necrotic tissue and numerous multinucleate foreign body giant cells. At day 14, the chronic infiltrate with eosinophils persisted when in contact with CPM. In the MTA group, necrosis and distant giant cells could still be seen. At day 30, all 3 groups showed mature fibrous collagenous tissue. These findings indicate a different response to the materials evaluated in this study. Although, MTA and CPM induced a chronic inflammatory infiltrate, necrosis and multinucleated foreign body giant cells predominated in the MTA group, while in the CPM group numerous eosinophils were seen at all the observational periods.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19738942     DOI: 10.1590/s0103-64402009000200004

Source DB:  PubMed          Journal:  Braz Dent J        ISSN: 0103-6440


  6 in total

1.  Biocompatibility of mineral trioxide aggregate and three new endodontic cements: An animal study.

Authors:  Mohammad-Ghasem Aminozarbian; Masoud Barati; Iman Salehi; Seyed Behrouz Mousavi
Journal:  Dent Res J (Isfahan)       Date:  2012-01

2.  Effect of the plant-based hemostatic agent Ankaferd Blood Stopper® on the biocompatibility of mineral trioxide aggregate.

Authors:  Muzaffer Emir Dinçol; Hakan Ozbas; Bulent Yılmaz; Handan Ersev; Selcuk Gokyay; Vakur Olgac
Journal:  BMC Oral Health       Date:  2016-10-11       Impact factor: 2.757

3.  Evaluation of biocompatibility of a new root canal irrigant Q Mix™ 2 in 1- An in vivo study.

Authors:  Veeramachaneni Chandrasekhar; Vanapatla Amulya; Vanapatla Swaroopa Rani; T Jaya Prakash; A Siva Ranjani; Ch Gayathri
Journal:  J Conserv Dent       Date:  2013-01

4.  In vivo biocompatibility of Resilon compared with gutta-percha in a pre-clinical model.

Authors:  Miguel Cardoso; Rodrigo F Marques; Maria Francelina Lopes; António S Cabrita; João Miguel Santos
Journal:  Dent Res J (Isfahan)       Date:  2013-09

5.  Evaluation of the biocompatibility of experimentally manufactured portland cement: An animal study.

Authors:  Sibel Koçak; Hülya Erten; Emre Baris; Serkan Türk; Tayfun Alaçam
Journal:  J Clin Exp Dent       Date:  2014-02-01

6.  Biocompatibility of Mineral Trioxide Aggregate Mixed with Different Accelerators: an Animal Study.

Authors:  Mitra Tabari; Maryam Seyed Majidi; Mahtab Hamzeh; Saeideh Ghoreishi
Journal:  J Dent (Shiraz)       Date:  2020-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.